Molecular remission at T cell level in patients with rheumatoid arthritis
Abstract While numerous disease-modifying anti-rheumatic drugs (DMARDs) have brought about a dramatic paradigm shift in the management of rheumatoid arthritis (RA), unmet needs remain, such as the small proportion of patients who achieve drug-free status. The aim of this study was to explore key mol...
Guardado en:
Autores principales: | Jun Inamo, Katsuya Suzuki, Masaru Takeshita, Yasushi Kondo, Yuumi Okuzono, Keiko Koga, Yoshiaki Kassai, Maiko Takiguchi, Rina Kurisu, Akihiko Yoshimura, Tsutomu Takeuchi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e11e293e5ff4fb8a57943a089d52458 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission
por: Shinya Tasaki, et al.
Publicado: (2018) -
Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy
por: Taisuke Kondo, et al.
Publicado: (2017) -
Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: Liam J. O’Neil, et al.
Publicado: (2021) -
Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
por: Sook Yan Lee, et al.
Publicado: (2021) -
Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability – Saudi Rheumatoid Arthritis Registry
por: Almoallim H, et al.
Publicado: (2019)